TSTickerStarGet alerts
Company alerts/JAGX
JAGX company alerts

JAGX updates worth following

TickerStar monitors official filings, investor releases, earnings, and call updates for JAGX. Subscribe to JAGX alerts to receive concise, source-linked alerts when TickerStar detects a meaningful company update.

Subscribe for JAGX alertsView companies
Official-source feed

Recent JAGX alert previews

TickerStar filters routine noise and surfaces investor-relevant filings, releases, earnings, and call updates.

Company updateOfficial company source

Jaguar Health updates proxy disclosure on 2014 Plan share reserve

No actual financial results were disclosed, so there is no beat, miss, or in-line outcome versus the supplied prior-guidance midpoint; that context also cites Guardant Health rather than Jaguar Health. Jaguar Health's supplement to its November 6, 2026 special-meeting proxy states that the Board unanimously approved a six-fold 2014 Plan share-reserve adjustment, effective immediately after the meeting, to preserve the plan at approximately 14% of fully diluted shares after the Series R conversion. If Proposal 3...

Read source-backed brief
Debt offeringSEC filing

JAGX schedules Special Meeting for November 6, 2026 to vote on six proposals including CVP exchange approval, warrant repricing, plan share increase, reverse split, and ELOC floor price reduction

Jaguar Health filed a definitive proxy statement for a Special Meeting of Stockholders on Friday, November 6, 2026 at 8:30 a.m. local time at 200 Pine Street, Suite 400, San Francisco, California. The record date is September 15, 2026, with 7,802,102 shares of voting common stock outstanding (approximately 520,140 after the September 17, 2026 1-for-15 reverse stock split). Stockholders will vote on six proposals: (i) approval under Nasdaq Rules 5635(b) and 5635(d) of share issuance upon exchange of Series Q Pref...

Read source-backed brief